MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
Status:
Completed
Trial end date:
2011-03-25
Target enrollment:
Participant gender:
Summary
A study to evaluate the efficacy and safety of sitagliptin and pioglitazone co-administration
in comparison with sitagliptin and pioglitazone monotherapy in patients with type 2 diabetes.